NCT00100711View on ClinicalTrials.gov

Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2010

Conditions
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Interventions
DRUG

Motexafin Gadolinium

Trial Locations (3)

55905

The Mayo Clinic, Rochester

60611

Northwestern University, Chicago

43210-1240

The Ohio State University, Columbus

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY